Testing effectiveness (Phase 2)Looking for participantsNCT07512427What this trial is testingPhase 1/2 Study of OPK-88006 in Healthy and Presumed MASH ParticipantsWho this might be right forMASH OPKO Health, Inc. 30
Testing effectiveness (Phase 2)Looking for participantsNCT06937749What this trial is testingIBI362 in Participants With Metabolic Dysfunction-Associated Steatohepatitis (MASH)Who this might be right forMetabolic Dysfunction-associated Steatohepatitis (MASH) Innovent Biologics (Suzhou) Co. Ltd. 165
Large-scale testing (Phase 3)Looking for participantsNCT06632444What this trial is testingLIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver FibrosisWho this might be right forMetabolic Dysfunction Associated Steatohepatitis (MASH)Liver Fibrosis Boehringer Ingelheim 1,800
Not applicableLooking for participantsNCT06813508What this trial is testingPrognostic Factors for HCC and Liver Transplantation in Patients With MASLD/MASHWho this might be right forMetabolic Dysfunction-Associated Steatotic Liver DiseaseHepatocellular CarcinomaMetabolic Dysfunction-Associated Steatohepatitis+1 more IRCCS Azienda Ospedaliero-Universitaria di Bologna 1,000
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07025980What this trial is testingEffect of Sinbiotic With Multispecies Probiotics on Liver Parameters Liver Enzymes, Ultrasound, Elastography and Adipokines in Same Cases) in Patients With Metabolic Associated Steatotic Liver Disease.Who this might be right forMASLD/MASH (Metabolic Dysfunction-Associated Steatotic Liver Disease / Metabolic Dysfunction-Associated Steatohepatitis)Diabetes MellitusHypertension+1 more Eva Cubric
Not applicableNot Yet RecruitingNCT07530419What this trial is testingSamsung S-Viscosity vs Canon Dispersion Slope in Steatotic Liver Disease (SAVID-SLD)Who this might be right forMetabolic Dysfunction-Associated Steatotic Liver DiseaseFatty LiverLiver Fibrosis Seoul National University Hospital 95
Testing effectiveness (Phase 2)Looking for participantsNCT07660848What this trial is testingHRS-4729 Injection and HRS9531 Injection in Participants With Metabolic Dysfunction-Associated SteatohepatitisWho this might be right forMetabolic Dysfunction-Associated Steatohepatitis (MASH) Fujian Shengdi Pharmaceutical Co., Ltd. 160
Post-approval studies (Phase 4)Not Yet RecruitingNCT07680478What this trial is testingNutrition Intervention Combined With Resmetirom for MASHWho this might be right forMetabolic Dysfunction-Associated Steatohepatitis (MASH) City University of New York 120
Not applicableEnrolling By InvitationNCT06986447What this trial is testingAssessment of Non-Invasive Testing in Major Liver-Related OutcomesWho this might be right forMetabolic Dysfunction-Associated Steatotic Liver DiseaseMASLDMASLD - Metabolic Dysfunction-Associated Steatotic Liver Disease+2 more HRI-MAIL-NIT 1,689
Post-approval studies (Phase 4)Looking for participantsNCT07058155What this trial is testingOptimizing Portal Hypertension With TIPS and Interval Metabolic Surgery for Advanced Liver DiseaseWho this might be right forLiver CirrhosesPortal Hypertension Related to CirrhosisSevere Obesity+1 more The Cleveland Clinic 70
Not applicableLooking for participantsNCT07188220What this trial is testingPatients' Perspectives on Metabolic Dysfunction-associated Steatohepatitis: a Qualitative StudyWho this might be right forMetabolic Dysfunction Associated Steatohepatitis (MASH) Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau 25
Not applicableLooking for participantsNCT07476703What this trial is testingExpanded Studies on the SCAPIS Stockholm Reexamination CohortWho this might be right forCoronary Artery DiseaseArterial Stiffness, Blood PressureAORTIC VALVE DISEASES+9 more Danderyd Hospital 1,400
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07631637What this trial is testingStudy to Evaluate ALN-CIDEB in Adults With Fibrotic Metabolic Dysfunction-Associated Steatohepatitis (MASH)Who this might be right forMetabolic Dysfunction-Associated Steatohepatitis (MASH) Regeneron Pharmaceuticals 150
Large-scale testing (Phase 3)Looking for participantsNCT07221227What this trial is testingA Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASHWho this might be right forNon-alcoholic Fatty Liver Disease GlaxoSmithKline 1,200
Testing effectiveness (Phase 2)Looking for participantsNCT07288138What this trial is testingA Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor, Alone and in Combination, in Adults With Presumed Metabolic Dysfunction-associated Steatohepatitis (MASH)Who this might be right forMetabolic Dysfunction-associated Steatohepatitis Eccogene 160
Not applicableActive Not RecruitingNCT07821749What this trial is testingA Prospective Study of Cold Exposure in Patients With MASHWho this might be right forMetabolic Dysfunction-Associated Steatohepatitis (MASH) Renmin Hospital of Wuhan University 11
Early research (Phase 1)Looking for participantsNCT05945537What this trial is testingINI-822 in Healthy Volunteers and Participants With Metabolic Dysfunction-Associated Steatohepatitis (MASH) or Presumed MASHWho this might be right forMetabolic Dysfunction-Associated Steatohepatitis Inipharm Australia Pty Ltd 168
Not applicableNot Yet RecruitingNCT07730853What this trial is testingIsocaloric Navy-Bean Substitution in Adults With MASLDWho this might be right forMetabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)Liver FibrosisMetabolic Dysfunction-Associated Steatohepatitis (MASH) Icahn School of Medicine at Mount Sinai 40
Testing effectiveness (Phase 2)Study completedNCT06342947What this trial is testingALG-055009 in Non-cirrhotic Adults With MASH (HERALD)Who this might be right forNASHMASHMetabolic Dysfunction-Associated Steatohepatitis+1 more Aligos Therapeutics 102
Not applicableEnrolling By InvitationNCT06703450What this trial is testingGuerbet Liver FibrosisWho this might be right forMetabolic Dysfunction-associated Steatotic Liver Disease Icahn School of Medicine at Mount Sinai 50